Clinical trial
Effects of Telomerase Reactivation With Danazol in Ovarian Function.
NCT04058678 is registered in ClinicalTrials.gov with IVI Madrid as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Telomerase Reactivation With Danazol in Ovarian Function.
- Lead sponsor
- IVI Madrid
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 30, 2020
- Completion date
- December 31, 2021
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ovarian reserve